In proliferative somatic tissues, insertions tend to substantially decrease with decreasing MMR dosage (i.e. from Mlh1+/+ to Mlh1+/− to Mlh1−/− tissue) with barely detectable insertions in MMR-deficient tissues and in MMR-deficient tumours, while deletions show the opposite trend. This evidence concerns the gene MRC1 and neoplasm.